Plasma Aryl Hydrocarbon Receptor Agonist Activity Is Associated With Inflammation and Metabolic Dysregulation in Obesity: A Cross‐Sectional Study
Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)
DOI: 10.1002/dmrr.70181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 07.06.2026. Verfasst von Fatemah Bahman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dasman Diabetes Institute, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Obesity, Inflammation, Biomarkers. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait Foundation for the Advancement of Sciences.
Abstract (Originalsprache)
Background
The aryl hydrocarbon receptor (AhR) is linked to inflammation, but its plasma agonist activity and association with metabolic and inflammatory markers in obesity remain unclear. This cross‐sectional study aimed to determine the level of plasma AhR agonistic activity and its association with systemic inflammation and metabolic dysregulation in obesity.
Methods
Plasma samples were collected from 80 non‐diabetic (39‐obese, 23‐overweight, and 18‐normal/healthy weight) individuals. AhR agonist activity was assessed using a cell‐based luciferase reporter assay. Plasma AhR was quantified by ELISA. Inflammatory markers were assessed using a multiplex Luminex platform.
Results
Our findings indicate that plasma AhR agonist activity is elevated in obese (92.77 ± 4.002 fold activation) compared with normal/healthy weight (51.39 ± 2.335) and overweight participants (67.54 ± 5.24 fold activation). Moreover, the AhR protein was also elevated in obese (94.88 ± 7.62 pg/ml) compared to normal/healthy weight (65.88 ± 6.78 pg/ml) and overweight participants (67.54 ± 5.24 pg/ml), which was positively correlated with AhR activity ( r = 0.441, p < 0.0001). AhR activity was positively correlated with inflammatory markers including IL‐1β, IL‐6, TNF‐α, TNF‐β, and MCP‐1, as well as metabolic markers such as BMI, total cholesterol, TG, insulin, FBG, and HbA1c. In contrast, it was negatively associated with HDL cholesterol. Notably, HOMA‐IR was positively correlated with AhR activity. In the regression model, TNF‐α, MCP‐1, BMI, and HDL cholesterol emerged as significant predictors of AhR activity.
Conclusions
Our findings demonstrate that elevated plasma AhR agonist activity is associated with obesity, systemic inflammation, and metabolic dysregulation. These results highlight AhR activity as a biomarker of interest and support further studies to clarify its mechanistic role and potential clinical relevance in metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dasman Diabetes Institute, Kuwait City, Kuwait.
ORCID-Profile: Fatemah Bahman, Shihab Kochumon, Ashraf Al Madhoun, Fahd Al-Mulla, Rasheed Ahmad
Förderung
- Kuwait Foundation for the Advancement of Sciences
Zitieren
APA
Bahman, F., Kochumon, S., Al Madhoun, A., Al-Roub, A., Bennakhi, A., Arouj, M., Al-Mulla, F., & Ahmad, R. (2026). Plasma Aryl Hydrocarbon Receptor Agonist Activity Is Associated With Inflammation and Metabolic Dysregulation in Obesity: A Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70181
Vancouver
Bahman F, Kochumon S, Al Madhoun A, Al-Roub A, Bennakhi A, Arouj M, et al. Plasma Aryl Hydrocarbon Receptor Agonist Activity Is Associated With Inflammation and Metabolic Dysregulation in Obesity: A Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70181
BibTeX
@article{Bahman2026,
author = {Bahman, Fatemah and Kochumon, Shihab and Al Madhoun, Ashraf and Al-Roub, Areej and Bennakhi, Abdullah and Arouj, Monira and Al-Mulla, Fahd and Ahmad, Rasheed},
title = {Plasma Aryl Hydrocarbon Receptor Agonist Activity Is Associated With Inflammation and Metabolic Dysregulation in Obesity: A Cross‐Sectional Study},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {5},
doi = {10.1002/dmrr.70181}
}
EUVIMED